Inflammatory Bowel Diseases (IBD): Clinical Trials

2 trials for Inflammatory Bowel Diseases (IBD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Inflammatory Bowel Diseases (IBD): new trials by email Literature Review of Inflammatory Bowel Diseases (IBD) trials Research Report on Inflammatory Bowel Diseases (IBD)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T - Inflammatory Bowel Diseases (IBD)
Phase 1 / Phase 2Not yet recruitingiCell Gene Therapeutics182026-04-072026-04-22
Fecal Microbiota Transplantation in Pediatric Patients
Fecal Microbiota Transplantation (FMT) - Inflammatory Bowel Diseases (IBD), Crohn's Disease (CD)
Phase 1CompletedChildren's Mercy Hospital Kansas City232014-03-012021-02-04

Narrower conditions

Colitis, Ulcerative (2)  ·  Crohn Disease (2)  ·  Inflammatory Bowel Diseases (2)

Broader conditions

Colitis (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)

Interventions

Fecal Microbiota Transplantation (1)

Sponsors

Children's Mercy Hospital Kansas City (1)  ·  iCell Gene Therapeutics (1)

Countries

China (1)  ·  United States (1)

Top investigators

Alka Goyal, MD (1)